Katherine Tarlock

1.7k total citations
53 papers, 775 citations indexed

About

Katherine Tarlock is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Katherine Tarlock has authored 53 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 19 papers in Molecular Biology and 17 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Katherine Tarlock's work include Acute Myeloid Leukemia Research (39 papers), Acute Lymphoblastic Leukemia research (16 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Katherine Tarlock is often cited by papers focused on Acute Myeloid Leukemia Research (39 papers), Acute Lymphoblastic Leukemia research (16 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Katherine Tarlock collaborates with scholars based in United States, Canada and United Kingdom. Katherine Tarlock's co-authors include Soheil Meshinchi, Todd M. Cooper, Alan S. Gamis, Todd A. Alonzo, Robert B. Gerbing, Colleen Annesley, Julie R. Park, Michael C. Jensen, Juliane Gust and Julie Rivers and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Katherine Tarlock

49 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katherine Tarlock United States	15	393	355	242	174	114	53	775
Lujia Dong China	10	428 1.1×	340 1.0×	94 0.4×	121 0.7×	58 0.5×	34	748
Patrick Schlegel Germany	17	329 0.8×	529 1.5×	200 0.8×	118 0.7×	62 0.5×	44	1.1k
Salyka Sengsayadeth United States	13	256 0.7×	257 0.7×	148 0.6×	61 0.4×	45 0.4×	41	502
Michael W. Boyer United States	14	299 0.8×	282 0.8×	151 0.6×	66 0.4×	131 1.1×	29	700
Linghui Xia China	11	287 0.7×	209 0.6×	82 0.3×	79 0.5×	79 0.7×	26	455
Don A. Stevens United States	15	223 0.6×	469 1.3×	234 1.0×	44 0.3×	149 1.3×	100	798
Katherine D. Cummins United States	8	175 0.4×	408 1.1×	281 1.2×	56 0.3×	35 0.3×	18	595
Xiaming Zhu China	11	224 0.6×	490 1.4×	131 0.5×	94 0.5×	30 0.3×	42	677
Mireya Paulina Velasquez United States	15	156 0.4×	589 1.7×	218 0.9×	38 0.2×	70 0.6×	42	783
Christopher Hunt Keir United States	12	115 0.3×	613 1.7×	326 1.3×	44 0.3×	80 0.7×	25	867

Countries citing papers authored by Katherine Tarlock

Since Specialization

Citations

This map shows the geographic impact of Katherine Tarlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Tarlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Tarlock more than expected).

Fields of papers citing papers by Katherine Tarlock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Tarlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Tarlock. The network helps show where Katherine Tarlock may publish in the future.

Co-authorship network of co-authors of Katherine Tarlock

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Tarlock. A scholar is included among the top collaborators of Katherine Tarlock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Tarlock. Katherine Tarlock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Benjamin J., Lauren K. Meyer, Todd A. Alonzo, et al.. (2025). Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 43(17). 1961–1971.

Tarlock, Katherine, Robert B. Gerbing, Rhonda E. Ries, et al.. (2024). Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia. Blood Advances. 8(9). 2094–2103. 4 indexed citations

Tarlock, Katherine, Xiaowei Liu, Charles G. Minard, et al.. (2023). Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712. Pediatric Blood & Cancer. 70(12). e30672–e30672. 2 indexed citations

Leonti, Amanda R., Laura Pardo, Cristina L. Abrahams, et al.. (2023). Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia. Blood Advances. 7(9). 1666–1670. 7 indexed citations

Srivastava, Shivani, Jenny L. Smith, Amanda R. Leonti, et al.. (2021). Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia. Clinical Cancer Research. 27(20). 5718–5730. 17 indexed citations

Tarlock, Katherine, Rhonda E. Ries, Yi‐Cheng Wang, et al.. (2021). KMT2A Partial Tandem Duplications (KMT2A-PTD) Is a Rare, but Recurrent Genomic Event in Childhood AML and Associated with High Rate of Co-Occurring FLT3 Mutations. Blood. 138(Supplement 1). 609–609. 1 indexed citations

Tarlock, Katherine, et al.. (2021). Targeted Therapy in Pediatric AML: An Evolving Landscape. Pediatric Drugs. 23(5). 485–497. 5 indexed citations

Tarlock, Katherine, Todd A. Alonzo, Yi-Cheng Wang, et al.. (2019). Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia. Clinical Cancer Research. 25(16). 5038–5048. 39 indexed citations

McNeil, Michael J., Marguerite T. Parisi, Nobuko Hijiya, et al.. (2018). Clinical and Radiographic Response of Extramedullary Leukemia in Patients Treated With Gemtuzumab Ozogamicin. Journal of Pediatric Hematology/Oncology. 41(3). e174–e176. 8 indexed citations

10.

Tarlock, Katherine, Todd A. Alonzo, Michael R. Loken, et al.. (2017). Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group. Clinical Cancer Research. 23(14). 3649–3656. 20 indexed citations

11.

Kaeding, Allison, Katherine Tarlock, Sonali P. Barwe, et al.. (2017). Mesothelin Is a Novel Disease Marker and Potential Therapeutic Target in Pediatric Acute Myeloid Leukemia. Blood. 130. 2641–2641. 1 indexed citations

12.

Tarlock, Katherine, Yuting He, James Sun, et al.. (2017). Recurrent Copy Number Variants Are Highly Prevalent in Acute Myeloid Leukemia. Blood. 130. 3800–3800. 1 indexed citations

13.

Cabrera, Michelle T., et al.. (2017). Rapidly Progressive, Isolated Subretinal Leukemic Relapse: A Case Report. Ocular Oncology and Pathology. 4(4). 220–224. 5 indexed citations

14.

Tarlock, Katherine, Todd A. Alonzo, Robert B. Gerbing, et al.. (2017). Functional Properties of Exon 17 KIT Mutations in Pediatric CBF AML Predict for Inferior Outcome and Enhanced Response to Tyrosine Kinase Inhibition: A Report from the Children's Oncology Group. Blood. 130. 25–25. 1 indexed citations

15.

Tarlock, Katherine, Todd A. Alonzo, Robert B. Gerbing, et al.. (2015). Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3 /ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group. Clinical Cancer Research. 22(8). 1951–1957. 42 indexed citations

16.

Tarlock, Katherine, et al.. (2014). Elevated fluoride levels and periostitis in pediatric hematopoietic stem cell transplant recipients receiving long‐term voriconazole. Pediatric Blood & Cancer. 62(5). 918–920. 11 indexed citations

17.

Tarlock, Katherine & Soheil Meshinchi. (2014). Pediatric Acute Myeloid Leukemia. Pediatric Clinics of North America. 62(1). 75–93. 45 indexed citations

18.

Tarlock, Katherine, Todd A. Alonzo, Robert B. Gerbing, et al.. (2014). Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3-ITD+ Acute Myeloid Leukemia: A Report from the Children's Oncology Group. Blood. 124(21). 486–486. 2 indexed citations

19.

Glick, Roberta P., Terry Lichtor, Henry Lin, Katherine Tarlock, & Edward P. Cohen. (2006). Immunogene therapy as a treatment for malignant brain tumors in young mice. Journal of Neurosurgery Pediatrics. 105(1). 65–70. 4 indexed citations

20.

Lichtor, Terry, et al.. (2002). Application of interleukin-2–secreting syngeneic/allogeneic fibroblasts in the treatment of primary and metastatic brain tumors. Cancer Gene Therapy. 9(5). 464–469. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact